International Advisory Board (IAB)

The purpose of the International Advisory Board is to provide guidance, feedback and to act as a critical friend to the Department on the implementation of the Department Strategy 2025-2030

The IAB’s role is advisory (non-executive).

Terms of Reference:

• To provide broad perspective and diverse insights to support the Department in achieving its vision and mission.
• To support the Department in identifying opportunities and providing advice to enable the Department to achieve its strategic aim to improve heath and transform lives.
• To provide the Department with object feedback and assessment on progress in implementation of its strategy.
• Provide insight on emerging scientific, policy, and practice trends in primary care and public health.
• Offer guidance on translation and implementation, innovation and partnerships (public, private, third sector), and research integrity and open science.
• Advise on education and training strategy (including doctoral, postdoctoral, and capacity-building initiatives).
• Comment on equality, diversity and inclusion (EDI) ambitions and global engagement.
• Highlight risks and mitigations relevant to the Department’s goals.
• To act as a critical friend and as ambassadors of the Department.

Authority and Reporting

The IAB reports to the Department Executive Committee.

Conduct, Confidentiality, and Data Protection

• Members will act with integrity, respect, and professionalism; they will not speak publicly on behalf of the Department without consent.
• Materials and discussions may be confidential; members must maintain confidentiality and handle information in line with applicable data protection laws (e.g., UK GDPR) and University policies.
• A register of interests will be maintained.

Conflicts of Interest

• Members must declare any actual or potential conflicts at appointment and at the start of relevant agenda items.
• The Chair (or Deputy) will determine appropriate management (e.g., partial exclusion from discussion/decision).

Remuneration and Expenses

Membership is normally unremunerated. Reasonable travel and subsistence costs for in-person attendance will be reimbursed in line with University policy and agreed in advance.

Frequency of Meetings

Annually for a period of one or two days at the discretion of the Chair. First meeting to be held in person and then subsequent annual meetings to alternate between online and in person.

Membership:

• Chair: Dr. Victor Dzau, President of the National Academy of Medicine
• Professor David Bates (Research and data science: health informatics and data science/AI lead, Harvard Medical School)
• Professor Ajay Singh (Executive education: Senior Associate Dean for Master's Academic Affairs, Office of Graduate Education, Harvard Medical School)
• Professor Dame Jenny Harries (Policy: former Deputy Chief Medical Officer of UK Government and Chief Executive, UK Health Security Agency)
• Professor Paul Little (Research: Primary care academic, Southampton and former chair of NIHR Programme Grants for Applied Research; chaired last Department Review).
• Dr Mairi Gibbs (Innovation: CEO of Oxford University Innovation)

Secretaries to the Committee: EAs to the HoD and HAF

Terms of Service

• Term length: 5 years to cover the period of the Department Strategy 2025 – 2030. 
• Resignation/Removal: members may resign by written notice; the HoD may end membership for cause (e.g., persistent non-attendance or conflict of interest concerns).